Venolasevascular Medicine is categorized under Health Services in West Nyack, NY and active since 2010.
Venolasevascular Medicine was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Donna Konlian at the company’s single location by writing to 2 Medical Park Drive # 4, West Nyack, New York NY 10994 or by phoning (845) 358-8878. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Venolasevascular Medicine |
| Contact Person: | Donna Konlian |
| Address: | 2 Medical Park Drive # 4, West Nyack, New York 10994 |
| Phone Number: | (845) 358-8878 |
| Website Address: | venolase.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Venolasevascular Medicine was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Donna Konlian for inquiries that concern Venolasevascular Medicine by calling the company number (845) 358-8878, as your correspondence is most welcome. Additionally, the physical location of the single location of Venolasevascular Medicine can be found at the coordinates 41.09553,-73.98397 as well as the street address 2 Medical Park Drive # 4 in West Nyack, New York 10994.
For its online presence, you may visit Venolasevascular Medicine’s website at venolase.com and engage with its social media outlets through on Twitter and on Facebook.